Memo Therapeutics secured CHF 5M from Redalpine, Investiere, Schroder Adveq and Zurcher Kantonal Bank. Biotech Health services Manufacturing Investments 08 May 2018 Share:
Round value (USD): 5.01m Round investors: Verve Ventures Redalpine Schroder Adveq Zürcher Kantonalbank Company: Memo Therapeutics Industry: Biotech Health services Manufacturing
Timeline Nutrition raises CHF8.4M series C Beauty Ecommerce Health services Manufacturing Investments 19 March 2018